Dr. Raymond Peter Puzio, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 217 N Providence Rd, Wallingford, PA 19086 Phone: 610-565-6306 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly owned subsidiary, Takeda Pharmaceuticals North America, Inc. have announced that Takeda's intellectual property rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS (pioglitazone HCl).
Researchers found that neither gender nor demographic characteristics affected juror satisfaction with overall service experience. Both men and women reported experiencing emotions during their trials.
Engineers at the University of California San Diego have developed a soft, stretchy skin patch that can be worn on the neck to continuously track blood pressure and heart rate while measuring the wearer's levels of glucose as well as lactate, alcohol or caffeine.
Genzyme Corporation (Nasdaq: GENZ) announced today that the FDA's Oncologic Drugs Advisory Committee voted 9 to 3 that a randomized, controlled trial is needed to support the currently proposed label expansion for Clolar® (clofarabine) in adult myeloid leukemia (AML). The committee found that the single-arm clinical study results submitted to support the label expansion showed Clolar was an active agent in acute AML patients, but concluded that a randomized clinical trial should be necessary to better interpret Clolar's efficacy and safety in the proposed patient population.
The Food and Drug Administration (FDA) in the United States has given it's approval for the first patch for Parkinson's disease.
› Verified 2 days ago